Stock Price
1.38
Daily Change
-0.02 -1.08%
Monthly
-15.12%
Yearly
16.53%
Q2 Forecast
1.38

Autolus Therapeutics Ltd reported $24.29M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
AstraZeneca USD 15.5B 313M Dec/2025
Autolus Therapeutics Ltd USD 24.29M 1.68M Dec/2025
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Novartis USD 13.86B 50M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Silence Therapeutics USD 39K 5K Mar/2026